Sharp Therapeutics (SHRX.V) Stock Price

Sharp Therapeutics Price

CLOSED
0.96
​
Market closed

Sharp Therapeutics stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sharp Therapeutics business model & stock analysis

Sharp Therapeutics Corp, headquartered in Toronto, Ontario, Canada, is a capital pool company listed on 4 August 2023. The company operates in the Health Care sector, focusing on identifying and evaluating assets or businesses for a qualifying transaction. It has not commenced operations or generated revenue to date.

Frequently asked questions about Sharp Therapeutics

Converted at the current exchange rate, the Sharp Therapeutics share trades at 0.86 EUR (0.96 USD).

The revenue cannot currently be calculated for Sharp Therapeutics.

The profit cannot currently be calculated for Sharp Therapeutics.

The P/E ratio cannot be calculated for Sharp Therapeutics at the moment.

The P/S cannot be calculated for Sharp Therapeutics currently.

The Eulerpool Quality Score for Sharp Therapeutics is 2/10.

The ISIN of Sharp Therapeutics is CA8200092077. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Sharp Therapeutics is SHRX.V. The ticker symbol is used to trade Sharp Therapeutics shares on the stock exchange.

Fair ValueTerminal
0.82 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Country
Currency
USD
Initial public offering
Aug 4, 2023
ISIN
CA8200092077
Cusip
26929F109
Market capitalization
28.91 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
11.19
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
3,496.15 %
Last updated Oct 17, 2026, 7:23 PM

Sharp Therapeutics Peer Group